SUMIRE (Symbicort in COPD patients)
Phase 3
Completed
- Conditions
- Health Condition 1: null- Chronic Obstructive Pulmonary Disease (COPD)Health Condition 2: J449- Chronic obstructive pulmonary disease, unspecified
- Registration Number
- CTRI/2010/091/000153
- Lead Sponsor
- AstraZeneca AB
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
A current clinical diagnosis of COPD
- Documented COPD symptoms for more than 2 years
- A smoking history of at least 10 pack years
Exclusion Criteria
- History and/or current clinical diagnosis of asthma
- History and/or current clinical diagnosis of atopic diseases such as allergic rhinitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method